Corporate GovernanceJun 2, 2026, 05:17 PM
Allarity Therapeutics Amends CEO Management Services Agreement
AI Summary
Allarity Therapeutics, Inc. entered into an Amended and Restated Management Services Agreement (A&R MSA) with Ljungaskog Consulting AB, owned by CEO Thomas H. Jensen, effective June 1, 2026. The A&R MSA updates compensation, bonus, and termination provisions for the CEO's services. Key changes include a revised annual base salary, elimination of a signing bonus, and increased termination payments for the consultant.
Key Highlights
- Allarity Therapeutics entered into an Amended and Restated Management Services Agreement (A&R MSA) with CEO's consulting firm, effective June 1, 2026.
- 2026 annual base salary for the consultant will be SEK 6,000,000 and US$163,043.
- The A&R MSA eliminates the one-time US$100,000 signing bonus from the original agreement.
- Annual bonus will be capped at 60% of the Monthly Fees paid to the consultant in a calendar year.
- Company's notice period for termination for convenience increased from 15 days to 30 days.
- Termination payment for company convenience or consultant good reason is now 12 months of the Monthly Fee.
- Original MSA provided only accrued payments for company convenience termination.
Price Impact
More from ALLR